GE HealthCare vs Stryker
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put GE HealthCare and Stryker side by side, using each one’s latest annual report. Here is what stands out:
- Stryker is the larger business, with $25.1B of revenue in fiscal 2025 against $20.6B for GE HealthCare.
- Stryker grew revenue faster (11.2%, against 4.8%).
- Stryker kept more of each dollar of sales as operating profit (19.5% operating margin, against 13.4%).
- Stryker turned more of its sales into free cash flow (17.1% FCF margin, against 7.3%).
- GE HealthCare earned a higher return on the capital invested in it (13.3%, against 11.3%).
- Investors pay more for each dollar of Stryker’s earnings: a P/E of 31.7x against 17.2x for GE HealthCare.
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
GE HealthCare
GEHC
4/10
Return on capitalReturn on equityPiotroski F-scoreShare count change
Stryker
SYK
6/10
Revenue growthGross marginOperating marginNet marginFCF marginNet debt / EBITDA
Side by side
Best in the row
| Latest fiscal year | GEHC FY25 | SYK FY25 |
|---|---|---|
| Size | ||
| Market cap | $32.9B | $118.2B |
| Revenue | $20.6B | $25.1B |
| Free cash flow | $1.5B | $4.3B |
| Net income | $2.1B | $3.2B |
| Growth | ||
| Revenue growth | 4.8% | 11.2% |
| 5-year growth | — | 11.8% |
| Share count change | −0.2% | 0.2% |
| Profitability | ||
| Gross margin | 40.0% | 64.0% |
| Operating margin | 13.4% | 19.5% |
| Net margin | 10.1% | 12.9% |
| FCF margin | 7.3% | 17.1% |
| Return on capital | 13.3% | 11.3% |
| Return on equity | 22.1% | 15.1% |
| Balance sheet | ||
| Net debt | $6.0B | $10.8B |
| Net debt / EBITDA | 1.8x | 1.7x |
| Dividends and buybacks | $264M | $1.3B |
| Valuation & quality | ||
| P/E | 17.2x | 31.7x |
| Piotroski F-score | 7 | 6 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.